Literature DB >> 25478194

JTD special edition 'Hot Topics in COPD'-The microbiome in COPD.

Daniel C Chambers1, Shaan L Gellatly1, Philip Hugenholtz1, Philip M Hansbro1.   

Abstract

The pathogenesis of chronic obstructive pulmonary disease (COPD) and its exacerbations, are intricately linked to colonisation and infection with bacteria and other microbes. Despite their undeniable importance, we have a poor understanding of the complex relationships between COPD phenotypes, physiology, cellular and molecular biology and the roles of colonising microbe or infecting pathogens. The management algorithms for the care of patients with COPD that include microbial influences, have almost exclusively been developed using microbial methods that were entirely dependent on the ability to grow bacteria on suitable media. The shortcomings of this approach are becoming clear now that it is possible to completely and accurately define the microbial ecology of ecosystems using genomic methods, which do not rely on the ability to cultivate the organisms present. Whilst our appreciation of the relationships between some bacterial ecosystems and the organ in which they reside in humans is now relatively advanced, this is not true for lung. This perspective serves to highlight the growing importance of including an accurate description of bacterial ecology in any attempt to decipher the pathobiology of COPD. While this field is in its infancy, there is significant potential to gain new insights which will translate into more rational and effective treatment algorithms for patients with COPD.

Entities:  

Keywords:  Chronic obstructive pulmonary disease (COPD); metagenomics; microbiome

Year:  2014        PMID: 25478194      PMCID: PMC4255167          DOI: 10.3978/j.issn.2072-1439.2014.11.08

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  48 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

2.  Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.

Authors:  Anders Ekbom; Lena Brandt; Fredrik Granath; Claes-Göran Löfdahl; Arne Egesten
Journal:  Lung       Date:  2008-03-11       Impact factor: 2.584

Review 3.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Timothy F Murphy
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

Review 4.  A renaissance for the pioneering 16S rRNA gene.

Authors:  Susannah G Tringe; Philip Hugenholtz
Journal:  Curr Opin Microbiol       Date:  2008-10-08       Impact factor: 7.934

Review 5.  Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity.

Authors:  P Hugenholtz; B M Goebel; N R Pace
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

6.  Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?

Authors:  Franziska A Stressmann; Geraint B Rogers; Peter Marsh; Andrew K Lilley; Thomas W V Daniels; Mary P Carroll; Lucas R Hoffman; Graeme Jones; Collette E Allen; Nilesh Patel; Benjamin Forbes; Andrew Tuck; Kenneth D Bruce
Journal:  J Cyst Fibros       Date:  2011-06-12       Impact factor: 5.482

7.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

8.  Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.

Authors:  Dana L Willner; Philip Hugenholtz; Stephanie T Yerkovich; Maxine E Tan; Joshua N Daly; Nancy Lachner; Peter M Hopkins; Daniel C Chambers
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

9.  Antibiotics in early life alter the murine colonic microbiome and adiposity.

Authors:  Ilseung Cho; Shingo Yamanishi; Laura Cox; Barbara A Methé; Jiri Zavadil; Kelvin Li; Zhan Gao; Douglas Mahana; Kartik Raju; Isabel Teitler; Huilin Li; Alexander V Alekseyenko; Martin J Blaser
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

10.  Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Lancet Respir Med       Date:  2014-03       Impact factor: 30.700

View more
  9 in total

Review 1.  COPD and the gut-lung axis: the therapeutic potential of fibre.

Authors:  Annalicia Vaughan; Zoe A Frazer; Philip M Hansbro; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 2.  Biomarkers of progression of chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annalicia Vaughan; Annette G Dent; Phoebe E O'Hare; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

3.  Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.

Authors:  Michael Fricker; Bridie J Goggins; Sean Mateer; Bernadette Jones; Richard Y Kim; Shaan L Gellatly; Andrew G Jarnicki; Nicholas Powell; Brian G Oliver; Graham Radford-Smith; Nicholas J Talley; Marjorie M Walker; Simon Keely; Philip M Hansbro
Journal:  JCI Insight       Date:  2018-02-08

Review 4.  Novel aspects of pathogenesis and regeneration mechanisms in COPD.

Authors:  Edvardas Bagdonas; Jovile Raudoniute; Ieva Bruzauskaite; Ruta Aldonyte
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-02

Review 5.  Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease.

Authors:  Reinoud Gosens; Pieter S Hiemstra; Ian M Adcock; Ken R Bracke; Robert P Dickson; Philip M Hansbro; Susanne Krauss-Etschmann; Hermelijn H Smits; Frank R M Stassen; Sabine Bartel
Journal:  Eur Respir J       Date:  2020-08-20       Impact factor: 16.671

6.  Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease.

Authors:  Tatt Jhong Haw; Malcolm R Starkey; Stelios Pavlidis; Michael Fricker; Anya L Arthurs; Prema M Nair; Gang Liu; Irwan Hanish; Richard Y Kim; Paul S Foster; Jay C Horvat; Ian M Adcock; Philip M Hansbro
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

Review 7.  Elucidating novel disease mechanisms in severe asthma.

Authors:  Richard Y Kim; Brittany Rae; Rachel Neal; Chantal Donovan; James Pinkerton; Lohis Balachandran; Malcolm R Starkey; Darryl A Knight; Jay C Horvat; Philip M Hansbro
Journal:  Clin Transl Immunology       Date:  2016-07-15

Review 8.  Microbiome effects on immunity, health and disease in the lung.

Authors:  Shakti D Shukla; Kurtis F Budden; Rachael Neal; Philip M Hansbro
Journal:  Clin Transl Immunology       Date:  2017-03-10

Review 9.  The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae.

Authors:  Yu-Ching Su; Farshid Jalalvand; John Thegerström; Kristian Riesbeck
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.